Actively Recruiting
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Led by Yale University · Updated on 2025-12-04
100
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
B
Boston Children's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
PtenTurkiye.org' is a national ( Turkish), web-based registry for PTEN Hamartoma Tumour ( PHTS) syndrome established in 2022. It is designed to increase awareness, gather scientific knowledge by collaboration and increase data accessibility, collect high-quality data on the epidemiology, genetic background and natural history of PHTS especially for pediatric patients so that more accurate follow up guidelines can be recommended.
CONDITIONS
Official Title
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinical signs of PTEN Hamartoma Tumor Syndrome (PHTS) and a mutation in the PTEN gene (including variants of uncertain significance showing clinical findings)
- Agreement to participate in the study
You will not qualify if you...
- Patients without clinical signs of PHTS and without a mutation in the PTEN gene
- Patients who do not agree to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr.Canan Kocaman pediatric clinic
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
H
Hande Kaymakcalan Celebiler, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here